Phytochemicals against anti-diabetic complications: targeting the advanced glycation end product signaling pathway

Citations

WEB OF SCIENCE

24
Citations

SCOPUS

32

초록

The role of advanced glycation end products (AGEs) is not limited to diabetes and diabetes-related complications. There are multiple modulators, including the receptor for advanced glycation end products, high mobility group box 1, glyoxalase 1, nuclear factor-kappa B, tumor necrosis factor-α, chronic unpredictable stress, reactive oxygen species, and inflammatory cytokines, which interact with AGE signaling and control diabetes, modulating these interacting modulators. The progression of diabetes, as well as related complications, can be controlled and treated. Natural products rich in bioactive constituents can interact with AGEs and their related mediators through various signaling cascades, thereby controlling and preventing the progression of diabetes. This review provides a deeper assessment of the signaling pathway, interactions between phytochemicals and AGEs, and its mediators, to develop a multifold therapeutic approach to prevent and treat diabetes and its related complications. © 2021, The Pharmaceutical Society of Korea.

키워드

Advanced glycation end productsCoronary artery diseaseDiabetesNitric oxidePhytochemicalsReactive oxygen speciesReceptor for advanced end product glycation
제목
Phytochemicals against anti-diabetic complications: targeting the advanced glycation end product signaling pathway
저자
Parveen, AmnaSultana, RaziaLee, Seung MinKim, Tae HunKim, Sun Yeou
DOI
10.1007/s12272-021-01323-9
발행일
2021-04
유형
Article in Press
저널명
Archives of Pharmacal Research
44
4
페이지
378 ~ 401